The exact molecular formula and molecular weight may vary when CJC-1295 (No DAC) is supplied as an acetate, trifluoroacetate, hydrate, or another salt form. Researchers should therefore verify the specific material designation, counterion composition, and analytical specifications listed on the Certificate of Analysis before performing molecular calculations or preparing experimental protocols.
Within controlled research environments, CJC-1295 (No DAC) may be studied in experimental models involving GHRH receptor interactions, peptide-binding characteristics, intracellular signaling mechanisms, structural modifications, ligand-receptor recognition, and peptide stability. Comparative research may also examine differences between modified GHRH analogs and their structural characteristics under defined biochemical conditions.
Establish experimental parameters independently for each protocol. Researchers should assess solvent compatibility, concentration, pH, peptide stability, analytical methodology, temperature sensitivity, storage conditions, and potential material interactions before incorporating CJC-1295 (No DAC) into a research workflow.
Research Applications
CJC-1295 (No DAC) may support controlled laboratory studies involving:
- Growth hormone-releasing hormone receptor research
- Peptide-receptor interaction studies
- GHRH receptor-binding analysis
- Molecular signaling pathway research
- Structure-activity relationship studies
- Ligand-receptor interaction analysis
- Synthetic peptide characterization
- Comparative GHRH analog research
- Analytical method development
- Peptide stability and degradation investigations
Storage and Handling
Store CJC-1295 (No DAC) according to the conditions specified on the product label, Certificate of Analysis, or accompanying technical documentation. Protect the material from excessive heat, moisture, direct light, and unnecessary environmental exposure. Storage requirements may differ depending on the peptide’s physical form, salt composition, and formulation characteristics.
For lyophilized material, keep the container securely sealed until required for controlled laboratory preparation. Once prepared in solution, stability may depend on solvent composition, concentration, temperature, pH, container material, and storage duration. Researchers should evaluate these conditions through appropriate stability assessments and validated analytical procedures.
Avoid repeated temperature fluctuations where possible. Use appropriate laboratory handling procedures and maintain accurate records of preparation dates, storage conditions, material identification, lot numbers, and analytical use. Follow documented laboratory protocols to support consistent material handling and experimental reproducibility.
Product Specifications
Product Name: CJC-1295 (No DAC)
Alternative Names: Modified GRF (1-29), Mod GRF 1-29, CJC-1295 Without DAC
Product Category: Synthetic GHRH analog peptide
Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
Peptide Length: 29 amino acid residues
CAS Number: 863288-34-0 (commonly referenced; confirm against product-specific documentation)
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ (free peptide)
Molecular Weight: Approximately 3367.9 g/mol (free peptide)
Structural Modification: D-Ala², Gln⁸, Ala¹⁵, Leu²⁷ substitutions; C-terminal amidation; no DAC modification
Material Form: Verify through lot-specific documentation
Salt Form: Verify through product-specific documentation
Appearance: Typically supplied as a lyophilized research material; confirm lot-specific documentation
Purity: Refer to lot-specific Certificate of Analysis
Container Type: Sealed research vial or product-specific container
Testing Documentation: Lot-specific analytical records, where provided
Intended Setting: Controlled laboratory research
Use Classification: Research use only
Human or Veterinary Use: Prohibited
Quality Assurance
Each lot of CJC-1295 (No DAC) should include appropriate product-specific documentation, where available. Analytical records may include identity confirmation, purity assessment, chromatographic analysis, mass-spectrometric results, molecular specifications, batch identification, and recommended storage conditions. These records support material characterization and traceability within controlled laboratory research environments.
Researchers should verify that the stated peptide sequence, molecular formula, molecular weight, salt form, purity, and lot number correspond with the Certificate of Analysis before beginning experimental work. Analytical documentation should also confirm that the supplied material matches the No DAC peptide structure rather than the DAC-modified variant, as these are chemically distinct materials.
Because molecular specifications may differ between the free peptide and acetate, trifluoroacetate, or other salt forms, lot-specific documentation should serve as the primary reference for analytical calculations, material identification, and experimental recordkeeping. Accurate verification of peptide identity and physicochemical characteristics supports consistency across research procedures and analytical evaluations.
Research Use Disclaimer
For laboratory research use only. Not for human or veterinary use. Not intended for injection, administration, diagnosis, treatment, cure, or prevention of any disease. Do not use this research product as a food, drug, cosmetic, dietary supplement, or household product.




Reviews
There are no reviews yet.